Show simple item record

dc.contributor.authorConseil exécutif, 118
dc.coverage.spatialGenèveen
dc.date.accessioned2012-03-15T10:38:23Z
dc.date.available2012-03-15T10:38:23Z
dc.date.issued2006
dc.identifier.govdocEB118/6
dc.identifier.urihttps://apps.who.int/iris/handle/10665/22198
dc.descriptionConseil exécutif, cent dix-huitième session, point 5.3 de l’ordre du jour provisoire, 8 pen
dc.language.isofren
dc.publisherOrganisation mondiale de la Santéen
dc.subjectPharmaceutical productsen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshDrug Resistance, Microbialen
dc.subject.meshDrug Utilizationen
dc.subject.meshPatient Care Managementen
dc.titleUsage rationnel des médicaments : le point sur la mise en œuvre de la stratégie des médicaments de l’OMS : rapport du Secrétariaten
dc.typeGoverning body documentsen
dc.subject.meshqualifieradministration and dosageen
dc.subject.meshqualifierstandardsen
dc.subject.meshqualifiersupply and distributioen
who.relation.languageVersion10665/21525en
who.relation.languageVersion10665/22954en
who.relation.languageVersion10665/24083en
who.relation.languageVersion10665/25228en
who.relation.languageVersion10665/21925en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

  • EB118
    29 May-1 June 2006

Show simple item record